Sign Up
bf/NASDAQ:CCCC_icon.jpeg

COM:C4THERAPEUTICS

C4 Therapeutics

  • Stock

USD

Last Close

4.01

22/11 21:00

Market Cap

344.03M

Beta: -

Volume Today

1.36M

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.13
-
0.18
36.77%
0.08
54.11%
0.09
8.91%
0.07
20.11%
0.06
23.61%
cash conversion cycle
139.27
-
cash per share
2.46
-
66.00
2,588.02%
32.69
50.47%
6.72
79.45%
5.65
15.86%
5.11
9.58%
company equity multiplier
-1.84
-
-1.06
42.50%
1.43
234.92%
1.30
8.72%
1.49
14.52%
1.53
2.68%
days of inventory outstanding
days of payables outstanding
68.22
-
days of sales outstanding
1.63K
-
78.92
95.16%
49.30
37.53%
45.57
7.58%
17.29
62.06%
207.49
1,100.06%
dividend yield
ebit per revenue
-0.85
-
-1.66
95.91%
-1.82
9.83%
-1.79
1.49%
-4.17
132.21%
-6.70
60.80%
ebt per ebit
0.96
-
0.94
2.03%
1.11
17.95%
1.02
7.79%
0.99
3.12%
0.94
4.62%
effective tax rate
-0.04
-
-0.02
44.04%
0.01
138.71%
-0.03
373.50%
0.01
151.14%
-0.01
174.60%
enterprise value multiple
-23.49
-
1.24
105.26%
-3.73
401.78%
-18.06
384.34%
-2.74
84.80%
-1.71
37.60%
fixed asset turnover
0.95
-
1.13
18.99%
2.01
77.43%
1.31
34.87%
0.40
69.29%
0.29
27.22%
free cash flow per share
-1.33
-
39.55
3,073.74%
-5.97
115.10%
-1.92
67.91%
-2.28
19.00%
-2.19
4.12%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
0.63
37.28%
interest coverage
-49.19
-
-38.29
22.15%
-58.45
52.66%
-101.26
73.23%
inventory turnover
long term debt to capitalization
-0.21
-
-0.13
37.65%
0.07
155.66%
0.10
33.31%
0.22
125.22%
0.21
2.84%
net income per ebt
1
-
1.02
2.41%
0.99
3.27%
1.03
3.52%
0.99
3.77%
1.01
2.31%
net profit margin
-0.81
-
-1.59
96.56%
-2.00
25.30%
-1.88
5.96%
-4.07
116.48%
-6.38
56.92%
operating cash flow per share
-1.15
-
40.54
3,630.27%
-5.91
114.59%
-1.89
68.06%
-2.17
14.79%
-2.15
0.73%
operating cycle
207.49
-
operating profit margin
-0.85
-
-1.66
95.91%
-1.82
9.83%
-1.79
1.49%
-4.17
132.21%
-6.70
60.80%
payables turnover
5.35
-
pretax profit margin
-0.81
-
-1.56
91.93%
-2.02
29.54%
-1.83
9.17%
-4.12
124.96%
-6.32
53.37%
price fair value
-4.73
-
-0.31
93.39%
1.34
529.53%
3.81
183.64%
1.00
73.81%
1.14
14.33%
receivables turnover
0.22
-
4.62
1,964.49%
7.40
60.07%
8.01
8.20%
21.11
163.55%
1.76
91.67%
return on assets
-0.11
-
-0.29
168.85%
-0.17
42.51%
-0.17
2.41%
-0.29
72.94%
-0.35
19.87%
return on capital employed
-0.13
-
-0.42
213.26%
-0.17
59.50%
-0.18
6.27%
-0.34
85.97%
-0.42
24.25%
return on equity
0.20
-
0.30
54.59%
-0.24
177.57%
-0.22
6.52%
-0.44
98.05%
-0.54
23.09%
total debt to capitalization
-0.22
-
-0.14
36.91%
0.08
153.91%
0.10
31.38%
0.23
133.54%
0.22
3.33%

All numbers in USD (except ratios and percentages)